Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis

PURPOSE: Four cycles of docetaxel/cyclophosphamide (DC) resulted in superior survival than doxorubicin/cyclophosphamide in the treatment of early breast cancer. The original study reported a 5% incidence of febrile neutropenia (FN) recommending prophylactic antibiotics with no granulocyte colony-sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yerushalmi, Rinat, Goldvaser, Hadar, Sulkes, Aaron, Ben-Aharon, Irit, Hendler, Daniel, Neiman, Victoria, Ciuraru, Noa Beatrice, Bonilla, Luisa, Amit, Limor, Zer, Alona, Granot, Tal, Rizel, Shulamith, Stemmer, Salomon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198090/
https://www.ncbi.nlm.nih.gov/pubmed/25330205
http://dx.doi.org/10.1371/journal.pone.0107273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198090/
https://www.ncbi.nlm.nih.gov/pubmed/25330205
http://dx.doi.org/10.1371/journal.pone.0107273

Ejemplares similares